lansoprazole has been researched along with Polycystic Kidney Diseases in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Polycystic Kidney Diseases: Hereditary diseases that are characterized by the progressive expansion of a large number of tightly packed CYSTS within the KIDNEYS. They include diseases with autosomal dominant and autosomal recessive inheritance.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lansoprazole has been reported as agonist of LXR, and shows an anti-proliferative effect in cancer cells." | 1.48 | Lansoprazole reduces renal cyst in polycystic kidney disease via inhibition of cell proliferation and fluid secretion. ( Chatsudthipong, V; Nantavishit, J; Soodvilai, S, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nantavishit, J | 1 |
| Chatsudthipong, V | 1 |
| Soodvilai, S | 1 |
1 other study available for lansoprazole and Polycystic Kidney Diseases
| Article | Year |
|---|---|
Lansoprazole reduces renal cyst in polycystic kidney disease via inhibition of cell proliferation and fluid secretion.
Topics: Animals; Cell Proliferation; Cyst Fluid; Dogs; Dose-Response Relationship, Drug; Humans; Lansoprazol | 2018 |